News at CenExel

CenExel Clinical Research Acquires Advanced Memory Research Institute

Salt Lake City, August 19, 2021 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”), the largest Alzheimer’s Disease clinical research site in the Northeast. CenExel AMRI...

RSV: Perspectives and Insight from a Healthcare Hero

As a former healthcare worker at Primary Children’s Hospital in Salt Lake City, UT, I begin to get more and more concerned about cold and flu season as it pertains to babies, as passing on a simple adult cold to an infant could be dangerous, even life-threatening....

CenExel Clinical Research Acquires ForCare Clinical Research

Salt Lake City, August 4, 2021 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years...

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours - ZYNRELEF is the first and only FDA-approved extended-release dual-acting local anesthetic, clinically proven to manage pain and to...

Translate »